Views & Analysis | Perspectives on pharma industry issues

Digital

What US healthcare companies and medical researchers need to...

How Italy’s pioneering AI Law and the EU AI Act impacts US healthcare companies and medical researchers operating in Italy.

Market Access

JPM 2026: What it revealed about biotech’s new reality

JPM 2026 signalled genuine recovery – but not the kind the industry has historically celebrated.

Sales & Marketing

Pharma’s search loophole is a preview of what comes next

PPC ads often contain so little text that they avoid direct claims. Many consist only of a brand name, a link, and limited copy.

Digital

Sponsored

Legacy data into living scientific memory

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now it’s possible to connect your data and tool ecosystem

R&D

Clinical trials, various research areas, concept

Clinical Trials Round-Up – Jan to Feb 2026

Read how Jan-Feb '26 offered a revealing cross-section of how R&D is evolving across therapy areas.

R&D

Sponsored

The pharma trends leading to higher demand for CDMOs

Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations.

R&D

LNPs: The unknown enabler behind mRNA vaccines

Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight.

Oncology

12 Questions with David Long

David Long leads the Oncology Business Unit at MSD in the UK and brings a wealth of experience from his 20 years within the organisation, having held a variety of local, regional and global

Sales & Marketing

Pharma’s search loophole is a preview of what comes next

PPC ads often contain so little text that they avoid direct claims. Many consist only of a brand name, a link, and limited copy.

Sales & Marketing

virtual electronic medical record interface

Sponsored

5 forces reshaping pharma commercialisation in 2026

As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment

Digital

What US healthcare companies and medical researchers need to...

How Italy’s pioneering AI Law and the EU AI Act impacts US healthcare companies and medical researchers operating in Italy.

Digital

Sponsored

Legacy data into living scientific memory

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now it’s possible to connect your data and tool ecosystem

Market Access

JPM 2026: What it revealed about biotech’s new reality

JPM 2026 signalled genuine recovery – but not the kind the industry has historically celebrated.

Market Access

What rare disease commercialisation in Europe teaches us - a...

Rare disease launches are the ultimate stress test for European commercialisation.

Oncology

Sponsored

Collaboration & personalisation in rare disease R&D, with AO...

For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.

Oncology